Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$155.22 - $162.74 $63,019 - $66,072
-406 Reduced 15.72%
2,176 $344,000
Q4 2023

Feb 12, 2024

SELL
$145.6 - $158.88 $44,408 - $48,458
-305 Reduced 10.56%
2,582 $404,000
Q2 2023

Aug 15, 2023

SELL
$154.35 - $166.11 $6,019 - $6,478
-39 Reduced 1.33%
2,887 $477,000
Q1 2023

Apr 14, 2023

BUY
$151.05 - $180.26 $10,422 - $12,437
69 Added 2.42%
2,926 $453,000
Q4 2022

Feb 10, 2023

BUY
$160.2 - $179.79 $13,937 - $15,641
87 Added 3.14%
2,857 $504,000
Q3 2022

Oct 26, 2022

BUY
$161.33 - $179.52 $14,842 - $16,515
92 Added 3.44%
2,770 $452,000
Q2 2022

Jul 22, 2022

SELL
$168.19 - $186.01 $37,506 - $41,480
-223 Reduced 7.69%
2,678 $476,000
Q1 2022

May 02, 2022

BUY
$158.14 - $179.59 $92,037 - $104,521
582 Added 25.1%
2,901 $514,000
Q4 2021

Feb 10, 2022

BUY
$155.93 - $173.01 $361,601 - $401,210
2,319 New
2,319 $398,000
Q3 2019

Oct 09, 2019

SELL
$126.95 - $142.14 $1.59 Million - $1.78 Million
-12,505 Closed
0 $0
Q2 2019

Aug 06, 2019

BUY
$131.15 - $144.24 $19,279 - $21,203
147 Added 1.19%
12,505 $1.74 Million
Q1 2019

May 13, 2019

BUY
$125.72 - $139.79 $34,070 - $37,883
271 Added 2.24%
12,358 $1.73 Million
Q4 2018

Feb 22, 2019

SELL
$122.84 - $147.84 $2.3 Million - $2.77 Million
-18,719 Reduced 60.76%
12,087 $1.56 Million
Q4 2018

Feb 07, 2019

BUY
$122.84 - $147.84 $2.34 Million - $2.82 Million
19,074 Added 162.58%
30,806 $3.98 Million
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $38,297 - $45,007
315 Added 2.76%
11,732 $1.64 Million
Q2 2018

Jul 31, 2018

BUY
$119.4 - $131.76 $72,475 - $79,978
607 Added 5.62%
11,417 $1.39 Million
Q1 2018

May 02, 2018

BUY
$125.1 - $148.14 $72,432 - $85,773
579 Added 5.66%
10,810 $1.36 Million
Q4 2017

Feb 13, 2018

BUY
$131.22 - $143.62 $1.34 Million - $1.47 Million
10,231
10,231 $1.43 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $379B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Bell & Brown Wealth Advisors, LLC Portfolio

Follow Bell & Brown Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell & Brown Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bell & Brown Wealth Advisors, LLC with notifications on news.